Discussion: This publication focuses on analyzing clinical outcomes (relapse risk) associated with switching antipsychotic treatments using Medicaid claims data. The study involves conducting a network analysis to test a clinical hypothesis about the comparative effectiveness of different antipsychotic treatments. It uses real-world data to generate evidence about treatment utilization and outcomes, which aligns with the goals of clinical evidence generation. The study does not focus on developing new methodologies, software tools, or data standards, but rather applies existing methods to produce clinical insights.

Final category: 4. **Clinical evidence generation**
